Docusign Inc. (NASDAQ:DOCU – Get Free Report) has been assigned a consensus rating of “Hold” from the eighteen research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $67.33.
DOCU has been the subject of several analyst reports. Royal Bank Of Canada increased their target price on shares of Docusign from $55.00 to $70.00 and gave the stock a “sector perform” rating in a report on Friday, September 4th. UBS Group lifted their price target on shares of Docusign from $54.00 to $70.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research note on Friday, September 4th. Citigroup increased their price target on Docusign from $54.00 to $72.00 and gave the stock a “neutral” rating in a research note on Friday, September 4th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $86.00 price objective on shares of Docusign in a research report on Friday, September 4th.
Check Out Our Latest Stock Analysis on DOCU
More Docusign News
- Positive Sentiment: Institutional investors own approximately 77.6% of Docusign, and several firms recently initiated or increased positions. Continued participation from large shareholders provides underlying support for DOCU. Docusign institutional ownership report
- Positive Sentiment: Docusign’s latest quarterly results exceeded expectations, with earnings of $1.16 per share versus the $1.09 consensus estimate and revenue of $875.75 million versus expectations of $867.22 million. Revenue rose 9.4% year over year, supporting the company’s growth and profitability outlook. Docusign earnings and AI outlook
- Neutral Sentiment: Kaspersky reported phishing campaigns impersonating Zoom and Docusign. The alert does not indicate a confirmed breach of Docusign, but continued impersonation could create reputational and cybersecurity concerns for investors. Kaspersky phishing campaign report
- Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans: CEO Allan Thygesen sold 26,250 shares for about $1.82 million, insider James Shaughnessy sold 12,000 shares for $825,600, CRO Paula Hansen sold 3,300 shares for $227,073, and Director Mary Wilderotter sold 1,000 shares for $68,800. Although these scheduled transactions do not necessarily signal deteriorating business conditions, their concentration can pressure sentiment and encourage profit-taking. Docusign executive stock sales
Docusign Stock Down 1.0%
Shares of NASDAQ:DOCU opened at $69.01 on Friday. The stock has a market capitalization of $12.90 billion, a PE ratio of 42.08, a price-to-earnings-growth ratio of 2.56 and a beta of 0.86. The firm’s 50 day moving average price is $63.52 and its 200-day moving average price is $52.98. Docusign has a twelve month low of $40.16 and a twelve month high of $75.00.
Docusign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping the consensus estimate of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The firm had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. During the same period in the prior year, the business posted $0.30 EPS. Docusign’s revenue was up 9.4% on a year-over-year basis. Analysts expect that Docusign will post 2.13 earnings per share for the current fiscal year.
Insider Activity
In related news, Director Mary Wilderotter sold 1,000 shares of the stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $68.80, for a total transaction of $68,800.00. Following the completion of the sale, the director owned 2,199 shares in the company, valued at approximately $151,291.20. This trade represents a 31.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 3,300 shares of Docusign stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $68.81, for a total value of $227,073.00. Following the sale, the executive directly owned 106,557 shares in the company, valued at $7,332,187.17. This trade represents a 3.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 165,868 shares of company stock valued at $11,121,890 in the last three months. 0.59% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Docusign
Hedge funds have recently made changes to their positions in the company. Versant Capital Management Inc grew its holdings in Docusign by 4.9% during the 3rd quarter. Versant Capital Management Inc now owns 7,179 shares of the company’s stock valued at $482,000 after buying an additional 335 shares in the last quarter. Greenwich Wealth Management LLC raised its stake in shares of Docusign by 30.0% in the second quarter. Greenwich Wealth Management LLC now owns 120,835 shares of the company’s stock valued at $5,367,000 after acquiring an additional 27,855 shares during the period. QRG Capital Management Inc. lifted its holdings in shares of Docusign by 31.2% in the 2nd quarter. QRG Capital Management Inc. now owns 11,132 shares of the company’s stock worth $495,000 after acquiring an additional 2,645 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its stake in shares of Docusign by 3.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 11,867 shares of the company’s stock worth $527,000 after purchasing an additional 356 shares during the period. Finally, Integrated Wealth Concepts LLC boosted its stake in shares of Docusign by 2.0% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock worth $638,000 after purchasing an additional 277 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
About Docusign
DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.
The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.
Recommended Stories
- Five stocks we like better than Docusign
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
